The effect of assisted reproductive drugs in endometriosis patients

Phase 2

Recruiting

• Conditions: Infertility.; Endometriosis of ovary; N80.1

• Registration Number: IRCT20200925048836N3
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

Women with a definite diagnosis of endometriosis based on pathology report
Aged between 21 and 35 years
The first period of using Assisted reproductive technology (ART) method
Normal serum Follicle stimulating hormone (FSH) concentration in primary follicular phase
Anti mullerian hormone (AMH) more than 0.5, presence of both ovary
Having the ART use indication that they are willing to participate in the study

Exclusion Criteria

History of uterine and ovary surgery
Poly cystic ovarian syndrome
Triggering with Human chorionic gonadotropin (HCG) drug
Severe fertilizing disorder in spouse
Patient with hypo gonadotrpic hypogonadism and uterine abnormality

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Oocyte maturation. Timepoint: Before and after treatment. Method of measurement: Transvaginal sonography.

Secondary Outcome Measures

Name	Time	Method
Oocyte yield. Timepoint: Before and after treatment. Method of measurement: Transvaginal sonography and hormonal assay.